BSF 302146Alternative Names: LU 302146
Latest Information Update: 23 Jan 2013
At a glance
- Originator Abbott GmbH & Co. KG
- Class Antihypertensives; Benzhydryl compounds; Heart failure therapies; Pyrimidines
- Mechanism of Action Endothelin receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Heart failure; Hypertension